Traws Pharma, Inc. / Fundamentals

    Income statement

    Net revenue
    €2.49M
    Cost of goods sold
    €2.57K
    Gross profit
    €2.49M
    SG&A expenses
    €9.78M
    R&D expenses
    €10.10M
    EBITDA
    -€17.10M
    D&A
    €5.15K
    EBIT
    -€17.39M
    Interest expenses
    €0.00
    EBT
    -€15.29M
    Tax expenses
    €0.00
    Net income
    -€15.29M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€17.87B
    Changes in working capital
    -€6.73M
    Operating cash flow
    -€9.81B
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €19.90M
    Debt repayment
    €0.00
    Other financing cash flow
    -€93.52K
    Net financing cash flow
    €19.81M
    Foreign exchange effects
    €36.04K
    Net change in cash
    -€3.26M
    Cash at end of period
    €11.22B
    Free cash flow
    -€9.81B

    Balance sheet

    Cash and cash equivalents
    €11.22M
    Cash and short-term investments
    €11.22M
    Total receivables
    €1.14M
    Inventory
    €0.00
    Other current assets
    €828.83K
    Total current assets
    €13.19M
    Property, plant & equipment
    €6.86K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €209.35K
    Total non-current assets
    €216.22K
    Total assets
    €13.40M
    Accounts payable
    €4.08M
    Short-term debt
    €0.00
    Other current liabilities
    €2.22M
    Total current liabilities
    €6.31M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €6.86K
    Total non-current liabilities
    €6.86K
    Total liabilities
    €6.31M
    Common stock
    €60.92K
    Retained earnings
    -€539.32M
    Other equity
    €7.72K
    Total equity
    €7.09M
    Total liabilities and shareholders' equity
    €13.40M

    Company information

    Market capitalization
    €7.64M
    Employees
    6
    Enterprise Value
    -€11.10M

    Company ratios

    Gross margin
    99.9%
    EBITDA margin
    -686.4%
    EBIT margin
    -698.1%
    EBT margin
    -613.9%
    Net margin
    -613.9%
    ROE
    -215.7%
    ROA
    -114.1%
    Asset turnover
    18.6%
    FCF margin
    -393,782.8%
    FCF yield
    -128,315.7%
    Efficiency ratio
    786.4%
    Net sales per employee
    €415.13K
    Net income per employee
    -€2.55M

    Notifications